Medtronic MiniMed’s Continuous Glucose Monitoring System (CGMS) improved kids’ control by providing them with accurate data—for adjustment of insulin treatments—and by promoting better communication and motivation.
French researchers, in an effort to determine the efficacy of the CGMS as an outpatient procedure in kids, observed 12 type 1 adolescents with an average age of 16 years.
All the children had poorly controlled type 1 with an average A1C of 10.1%.
- According to the researchers, CGMS profiles demonstrated blood glucose readings not recognized by capillary measurements in all 12 patients.
- Before- and after-meal blood glucose varied from 60 to 200 mg/dl in two patients.
- After-meal high blood glucose exceeded 200 mg/dl in 10 patients (24 episodes)
- Prolonged overnight high blood glucose was observed in five patients.
- Dawn phenomenon (early-morning rise in blood glucose) was observed in four patients.
- Nighttime hypoglycemia was observed in four patients.
- Based on CGMS data, insulin treatment was adjusted.
Two months later A1Cs dropped to an average of 8.75%, and a significant reduction of extremes in glucose excursions was shown in 8 of the patients.
Diabetes Metabolism, December 2003